XML 25 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Cash, Cash Equivalents and Investments
6 Months Ended
Jun. 30, 2022
Cash, Cash Equivalents and Investments  
Cash, Cash Equivalents and Investments

Note 3 - Cash, Cash Equivalents and Investments

The following tables summarize our cash, cash equivalents, marketable securities, and available-for-sale investments at June 30, 2022 and December 31, 2021 (in thousands):

As of June 30, 2022

    

  

Gross

  

Gross

  

  

 

Cash and

  

  

  

Amortized

Unrealized

Unrealized

 

Cash

Marketable

Short-Term

Long-Term

Cost

Gains

Losses

Fair Value

 

Equivalents

Securities

Investments

Investments

Cash

$

155,582

$

$

$

155,582

$

155,582

$

$

$

Level 1:

 

  

 

  

 

  

 

  

 

  

 

  

 

Money market funds

 

43,550

 

 

43,550

 

43,550

 

 

Agency bonds

 

26,601

5

 

(2)

 

26,604

 

8,484

 

 

18,120

Treasury bills

28,390

(24)

28,366

22,690

5,676

Marketable securities

90,000

(44,100)

45,900

 

 

45,900

 

Subtotal

 

188,541

5

 

(44,126)

 

144,420

52,034

45,900

40,810

5,676

Level 2:

State and municipal obligations

5,814

1

(35)

5,780

4,257

1,523

Corporate bonds

57,609

11

(1,027)

56,593

5,199

33,668

17,726

Commercial paper

39,779

39,779

39,779

Subtotal

103,202

12

(1,062)

102,152

5,199

77,704

19,249

Total

$

447,325

$

17

$

(45,188)

$

402,154

$

212,815

$

45,900

$

118,514

$

24,925

As of June 30, 2022, we had $86.7 million of investments with unrealized losses.

During the year ended December 31, 2021, we acquired 9,000,000 shares of common stock of Cellebrite DI Ltd (“CLBT”) with a fair value of $90.0 million. The CLBT common stock is recorded as marketable securities in the accompanying condensed consolidated balance sheets and its fair value is adjusted every reporting period. Changes in fair value are recorded in the condensed consolidated statement of operations as unrealized gain or (loss) on marketable securities, which is included in interest and other income, net. During the three and six months ended June 30, 2022, we recorded an unrealized loss on marketable securities of $11.7 million and $26.3 million, respectively, relating to CLBT.

As of December 31, 2021

  

  

Gross

  

Gross

  

  

 

Cash and

  

  

  

Amortized

Unrealized

Unrealized

 

Cash

Marketable

Short-Term

Long-Term

Cost

Gains

Losses

Fair Value

 

Equivalents

Securities

Investments

Investments

Cash

$

353,488

$

$

$

353,488

$

353,488

$

$

$

Level 1:

 

  

 

  

 

  

 

  

 

  

 

  

 

Money market funds

 

2,844

 

 

2,844

 

2,844

 

 

Agency bonds

 

10,700

4

 

 

10,704

 

 

 

10,704

Marketable securities

90,000

(17,820)

72,180

 

 

72,180

 

Subtotal

 

103,544

4

 

(17,820)

 

85,728

2,844

72,180

10,704

Level 2:

State and municipal obligations

2,570

(5)

2,565

1,400

1,165

Corporate bonds

32,748

1

(276)

32,473

2,406

30,067

Subtotal

35,318

1

(281)

35,038

3,806

31,232

Total

$

492,350

$

5

$

(18,101)

$

474,254

$

356,332

$

72,180

$

14,510

$

31,232